News
GLP-1 drugs are blockbuster medications for weight loss and Type 2 diabetes. Now doctors are trying them for lymphedema, ...
People are buying semaglutide and tirzepatide, the key ingredients in Ozempic and Zepbound, from unconventional sources. Doctors have safety concerns.
Denmark’s economy was reshaped by Novo Nordisk and obesity drugs. That identity now is under attack on multiple fronts, from ...
The U.S. Food and Drug Administration (FDA) approved Zepbound (tirzepatide) for the treatment of moderate to severe ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results